newsfilter
← Latest News
PR Newswire·

Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will...